TABLE 6.
Patients with early graft loss
| Recipient age/gender | Cause of liver disease/MELD | Tx year | Donor age/BMI | Local vs import | Flush | WIT(min) | aWIT(min) | DHT(min) | CIT(h) | Disposition |
|---|---|---|---|---|---|---|---|---|---|---|
| 55 M | PSC/23 | 2007 | 53/28.9 | Local | HTK | 22 | 22 | 39 | 5.5 | HAT. Retransplanted. Alive. |
| 64 M | HCV/40 | 2011 | 25/26.1 | Local | UW | 13 | 11 | 21 | 3.78 | Intraoperative death. |
| 64 M | HCV/8 | 2015 | 35/35.9 | Import | UW | 23 | 22 | 11 | 4.28 | PVT. Death. |
| 49 M | Neuroendocrine tumor/18 | 2016 | 34/25.9 | Import | UW | 19 | 7 | 51 | 9.68 | HAT. Retransplanted. Alive. |
| 55 M | HCV/24 | 2016 | 21/18.9 | Import | UW | 17 | 14 | 11 | 5.33 | Intraoperative death. |
| 37 M | HCV and HBV/28 | 2016 | 48/23.8 | Import | UW | 31 | 24 | 20 | 5.12 | PNF. Retransplanted. Alive. |
| 32 F | Tylenol/fulminant | 2017 | 24/32.3 | Import | UW | 22 | 22 | 22 | 4.6 | PNF. Retransplanted. Alive. |
aWIT, agonal warm ischemic time; BMI, body mass index; CIT, cold ischemic time; DHT, donor hepatectomy time; F, female; HAT, hepatic artery thrombosis; HBV, hepatitis B virus; HCV, hepatitis C virus; HTK, histidine-tryptophan-ketoglutarate solution; M, male; MELD, model for end-stage liver disease; PNF, primary nonfunction; PSC, primary sclerosing cholangitis; PVT, portal vein thrombosis; Tx, transplant; UW, University of Wisconsin solution; WIT, donor warm ischemic time.